Ajanta Pharma promoter reshuffles pledged shares, net position unchanged
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.3 pts more than Nifty Midcap 150 and 1.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoter Aayush Agrawal (trustee) disclosed release of pledge on 21,61,067 shares and simultaneous creation of a new pledge on the same number of shares. The released pledge was for a new loan, while the new pledge serves as security for issuance of non-convertible debentures held by CTL Trusteeship on behalf of 360 ONE income funds and other investors. Post-event, his pledged holding stands at 1,35,32,924 shares (10.83% of capital), unchanged. Several other promoters also saw pledge releases on July 22-23 and new creations on July 24, indicating a refinancing exercise across the promoter group.
Net pledged shares remain the same, so no dilution of free float. Pledge for non-convertible debentures signals promoter group is raising fresh capital.